FDA approves new weight loss drug Zepbound [ZVcVTvGPxfU]

FDA approves new weight loss drug Zepbound [ZVcVTvGPxfU]

| 1h 28m 28s | Video has closed captioning.

The FDA approved a new drug for obesity, Zepbound, made by Eli Lilly, which is potentially more effective at losing weight than any other drug on the market. The medication is already being sold as diabetes drug Mounjaro. NBC News’ Stephanie Gosk has more details. » Subscribe to NBC News: » Watch more NBC video: NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows. Connect with NBC News Online! NBC News App: Breaking News Alerts: Visit NBCNews.Com: Find NBC News on Facebook: Follow NBC News on Twitter: Get more of NBC News delivered to your inbox: nbcnews.com/newsletters #FDA #WeightLoss #Medication